Charles A. Deignan is Chief Financial Officer of Clearside Biomedical, Inc.. Currently has a direct ownership of 384,662 shares of CLSD, which is worth approximately $500,060. The most recent transaction as insider was on Jan 19, 2024, when has been sold 12,900 shares (Common Stock) at a price of $1.28 per share, resulting in proceeds of $16,512. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 385K
0% 3M change
3.24% 12M change
Total Value Held $500,060

Charles A. Deignan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 19 2024
SELL
Open market or private sale
$16,512 $1.28 p/Share
12,900 Reduced 3.24%
384,662 Common Stock
Sep 13 2023
BUY
Exercise of conversion of derivative security
$13,636 $0.4 p/Share
34,090 Added 7.9%
397,562 Common Stock
Jan 19 2023
SELL
Open market or private sale
$21,045 $1.5 p/Share
14,030 Reduced 3.72%
363,472 Common Stock
Dec 20 2022
BUY
Exercise of conversion of derivative security
$9,454 $0.4 p/Share
23,636 Added 5.89%
377,502 Common Stock
Jan 19 2022
SELL
Open market or private sale
$18,461 $2.09 p/Share
8,833 Reduced 2.45%
351,366 Common Stock
Jan 18 2022
BUY
Grant, award, or other acquisition
-
43,750 Added 10.83%
360,199 Common Stock
Sep 21 2021
SELL
Open market or private sale
$17,948 $6.41 p/Share
2,800 Reduced 0.88%
316,449 Common Stock
Jun 21 2021
SELL
Open market or private sale
$12,839 $4.37 p/Share
2,938 Reduced 0.91%
319,249 Common Stock
Jan 18 2021
BUY
Grant, award, or other acquisition
-
96,360 Added 23.02%
322,187 Common Stock
CAD

Charles A. Deignan

Chief Financial Officer
Alpharetta, GA

Track Institutional and Insider Activities on CLSD

Follow Clearside Biomedical, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLSD shares.

Notify only if

Insider Trading

Get notified when an Clearside Biomedical, Inc. insider buys or sells CLSD shares.

Notify only if

News

Receive news related to Clearside Biomedical, Inc.

Track Activities on CLSD